(Q59485383)

English

Bioavailability of nasally administered progesterone**Supported by Nastech Pharmaceutical Company, Inc., Hauppauge, New York, and by a grant (RR-30) from the General Clinical Research Centers Program, Division of Resources, National Institutes of Hea

scholarly article by John F. Steege et al published October 1986 in Fertility and Sterility

In more languages
default for all languages
No label defined

No description defined

Statements

Bioavailability of nasally administered progesterone**Supported by Nastech Pharmaceutical Company, Inc., Hauppauge, New York, and by a grant (RR-30) from the General Clinical Research Centers Program, Division of Resources, National Institutes of Hea (English)
0 references
John F. Steege
0 references
Sharon L. Rupp
0 references
Anna L. Stout
0 references
Marc Bernhisel
0 references
October 1986
0 references
46
0 references
4
0 references
727-729
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit